November 19, 2020
Jessica Huber, a professor of speech, language, and hearing sciences and associate dean for research in Purdue University’s College of Health and Human Sciences, decided to investigate the use of remote technology to calibrate the SpeechVive, an ear-worn device that provides immediate speech volume and clarity improvement for people with Parkinson’s disease. Huber wanted to find a way to serve patients in rural and remote areas.
Parkinson’s patients use telehealth access for immediate speech improvement during COVID-19 pandemic
October 1, 2020
Shriram Ramanathan, Hyowon “Hugh” Lee, and Alexander Chubykin discover a new material that may help scientists learn more about neurological disorders and possibly take some big steps toward brain-machine interfaces.
September 29, 2020
In the midst of a global pandemic, Purdue's Department of Chemistry had to accelerate its “next-generation digital learning environment for chemistry.” This led to a futuristic lab for the students, complete with digital lab manuals and notebooks.
Purdue Has the Chemistry Lab of the Future Today, Complete with All-Digital Lab Manuals and Notebooks
September 10, 2020
A pair of Purdue University researchers developed small molecules to combat deadly, drug-resistant enterococcus. Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States.
September 1, 2020
Julia Chester, professor of psychological sciences at Purdue University, who studies stress and drinking behaviors, said that pandemic-related social stressors could point to an increase in alcohol consumption and drinking behaviors. According to survey results from an RTI International study, the average daily alcohol intake increased from approximately 0.74 drinks in February to 0.94 drinks in April. Current social stressors include persistent changes in relation to safety guidelines and isolation from quarantining or social distancing.
August 14, 2020
The Purdue team developed a fully implantable radio-frequency transmitter chip for wireless sensor nodes and biomedical devices. The research is published in the journal IEEE Transactions on Circuits and Systems II. The transmitter chip consumes lowest amount of energy per digital bit published to date.
Implantable transmitter provides wireless option for biomedical devices
August 11, 2020
A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer’s disease neurodegeneration.
NIH grant to help fast-track Neurodon’s Alzheimer’s drug development research
August 11, 2020
Doug Brubaker, a Purdue assistant professor of biomedical engineering, uses computational and experimental approaches to study host-microbiome interactions in cancers and inflammatory diseases.
Computational model could improve success in translating drugs from animal studies to humans
August 10, 2020
Dr. Shi specializes in uncovering the mechanisms of central nervous system trauma and diseases and instituting new treatments through innovative experimentation and pioneering new strategies in the field. In addition to being a professor of basic medical sciences in the Purdue College of Veterinary Medicine, he holds a courtesy appointment in Purdue’s Weldon School of Biomedical Engineering. In 2019, Shi was appointed director of the Center for Paralysis Research at Purdue. Shi is the author or co-author of 167 published papers and is the recipient of 12 issued patents. Two of his therapies have gone to clinical trials for spinal cord and head trauma, and one has gained FDA approval for patients with multiple sclerosis.
Riyi Shi, appointed as the Mari Hulman George Endowed Professor of Applied Neuroscience in the College of Veterinary Medicine.
July 23, 2020
PIIN members, Dr. Gaurav Chopra and Riyi Shi, professors at Purdue University, have received new support as they research traumatic brain injury and Alzheimer’s disease.
Purdue innovators receive $1.3 million from Department of Defense for research on traumatic brain injury and Alzheimer’s.
